Network pharmacology study to explore the multiple molecular mechanism of SH003 in the treatment of non-small cell lung cancer.

Lee, Kangwook; Choi, Yu-Jeong; Lim, Hae-In; Cho, Kwang Jin; Kang, Nuri; Ko, Seong-Gyu

Lee, Kangwook; Choi, Yu-Jeong; Lim, Hae-In; Cho, Kwang Jin; Kang, Nuri; Ko, Seong-Gyu.

Afiliação

Lee K; Department of Food and Biotechnology, Korea University, Sejong, 30019, South Korea.
Choi YJ; Department of Preventive Medicine, College of Korean Medicine, Kyung Hee University, Seoul, 02447, South Korea.
Lim HI; Department of Science in Korean Medicine, Graduate School, Kyung Hee University, Seoul, 02447, South Korea.
Cho KJ; Department of Science in Korean Medicine, Graduate School, Kyung Hee University, Seoul, 02447, South Korea.
Kang N; Department of Science in Korean Medicine, Graduate School, Kyung Hee University, Seoul, 02447, South Korea.
Ko SG; Department of Korean Medicine, Graduate School, Kyung Hee University, Seoul, 02447, South Korea.

BMC Complement Med Ther ; 24(1): 70, 2024 Feb 01.

Article em En | MEDLINE | ID: mdl-38303001

Assuntos

Carcinoma Pulmonar de Células não Pequenas; Neoplasias Pulmonares; Humanos; Carcinoma Pulmonar de Células não Pequenas/tratamento farmacológico; Farmacologia em Rede; Neoplasias Pulmonares/tratamento farmacológico; Inibidores da Angiogênese; Western Blotting

Palavras-chave

Gene ontology; KEGG; Network pharmacology; Non-small cell lung cancer; SH003

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google